What is he best known for?
The fields of study he is best known for:
Vladimir P. Torchilin mainly focuses on Liposome, Drug carrier, Drug delivery, Nanocarriers and Biophysics.
His Liposome study deals with the bigger picture of Biochemistry.
His Drug carrier study integrates concerns from other disciplines, such as Biodistribution, Amphiphile, Micelle, Polymer chemistry and Targeted drug delivery.
His Drug delivery research incorporates elements of Dosage form, Pharmacology, Drug, Tumor targeting and Peptide.
Vladimir P. Torchilin interconnects Dendrimer, Internalization, Nanomedicine and Cell-penetrating peptide in the investigation of issues within Nanocarriers.
The various areas that Vladimir P. Torchilin examines in his Biophysics study include Phosphatidylcholine, Vascular permeability, Pathology, Intravital microscopy and Polyethylene glycol.
His most cited work include:
- Recent advances with liposomes as pharmaceutical carriers. (3566 citations)
- Biodegradable long-circulating polymeric nanospheres (2380 citations)
- Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment (1910 citations)
What are the main themes of his work throughout his whole career to date?
Vladimir P. Torchilin focuses on Liposome, Drug delivery, Pharmacology, Biochemistry and Biophysics.
His studies deal with areas such as In vivo, In vitro, Intracellular, Drug carrier and Nanocarriers as well as Liposome.
The concepts of his Drug carrier study are interwoven with issues in Targeted drug delivery and Biodistribution.
His study with Drug delivery involves better knowledge in Nanotechnology.
He works mostly in the field of Pharmacology, limiting it down to concerns involving Doxorubicin and, occasionally, Cytotoxicity and Cancer research.
His Biophysics study which covers Micelle that intersects with Ethylene glycol, Amphiphile and Polyethylene glycol.
He most often published in these fields:
- Liposome (38.97%)
- Drug delivery (20.49%)
- Pharmacology (20.63%)
What were the highlights of his more recent work (between 2013-2021)?
- Drug delivery (20.49%)
- Cancer cell (14.33%)
- Cancer research (13.18%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Drug delivery, Cancer cell, Cancer research, Pharmacology and Liposome.
His research investigates the connection between Drug delivery and topics such as Drug that intersect with issues in Combination therapy.
The study incorporates disciplines such as Apoptosis, Biochemistry, Programmed cell death and Cytotoxicity in addition to Cancer cell.
In his work, Micelle and Spheroid is strongly intertwined with Biophysics, which is a subfield of Cytotoxicity.
Vladimir P. Torchilin works mostly in the field of Pharmacology, limiting it down to topics relating to Paclitaxel and, in certain cases, Tariquidar.
He focuses mostly in the field of Liposome, narrowing it down to matters related to Intracellular and, in some cases, Endocytosis.
Between 2013 and 2021, his most popular works were:
- Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery (790 citations)
- New Developments in Liposomal Drug Delivery. (654 citations)
- Stimuli-sensitive nanopreparations for combination cancer therapy. (213 citations)
In his most recent research, the most cited papers focused on:
Pharmacology, Drug delivery, In vivo, Doxorubicin and Cancer cell are his primary areas of study.
His Drug delivery research includes elements of Micelle and Drug.
Vladimir P. Torchilin has included themes like Biophysics, Nanotechnology and Polymer in his Micelle study.
His work deals with themes such as Cell, Cancer therapy and Cytotoxicity, which intersect with Doxorubicin.
His Cancer cell research focuses on Cancer research and how it relates to Liposome, Carcinogenesis, Pathology and Kidney.
His research is interdisciplinary, bridging the disciplines of Transferrin and Liposome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
